ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134459; 2) Community: the network communities that were significantly associated with the response to NSC 134459; 3) Molecule: the relationships between components within communities and NSC 134459; 4) MDR: the compounds that were significantly associated with the NSC 134459.

NSC Compound Enrichment Correlation
NSC 691562 [1]Benzothiepino[4,5-c]pyridine-1-carbonitrile, 2-amino-4-(3,4-dimethoxyphenyl)-5,6-dihydro-10-methyl- 0.0137891122538509 0.18541729
NSC 693135 Null 0.0137891122538509 0.39141067
NSC 693867 Null 0.0137891122538509 0.43174906
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0137891122538509 0.36894665
NSC 694075 Null 0.0137891122538509 0.26323872
NSC 697504 Null 0.0137891122538509 0.44698448
NSC 700363 Liposomal Annamycin 0.0137891122538509 0.54358458
NSC 705870 Null 0.0137891122538509 0.25756661
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0137891122538509 0.29485044
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0137891122538509 0.5926665
Total:128  Current:62    [First] [Prev] [Next] [Last]